Agios Pharmaceuticals Inc (AGIO)
55.55
+0.93
(+1.70%)
USD |
NASDAQ |
Nov 21, 16:00
55.55
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Price to Book Value: 1.948 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.915 |
| November 19, 2024 | 1.908 |
| November 18, 2024 | 1.854 |
| November 15, 2024 | 1.886 |
| November 14, 2024 | 1.942 |
| November 13, 2024 | 2.054 |
| November 12, 2024 | 2.069 |
| November 11, 2024 | 2.120 |
| November 08, 2024 | 2.071 |
| November 07, 2024 | 1.931 |
| November 06, 2024 | 1.809 |
| November 05, 2024 | 1.637 |
| November 04, 2024 | 1.572 |
| November 01, 2024 | 1.573 |
| October 31, 2024 | 1.558 |
| October 30, 2024 | 1.623 |
| October 29, 2024 | 1.642 |
| October 28, 2024 | 1.616 |
| October 25, 2024 | 1.581 |
| October 24, 2024 | 1.580 |
| October 23, 2024 | 1.554 |
| October 22, 2024 | 1.591 |
| October 21, 2024 | 1.601 |
| October 18, 2024 | 1.595 |
| October 17, 2024 | 1.547 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.532 |
| October 15, 2024 | 1.474 |
| October 14, 2024 | 1.447 |
| October 11, 2024 | 1.495 |
| October 10, 2024 | 1.466 |
| October 09, 2024 | 1.433 |
| October 08, 2024 | 1.420 |
| October 07, 2024 | 1.423 |
| October 04, 2024 | 1.449 |
| October 03, 2024 | 1.422 |
| October 02, 2024 | 1.465 |
| October 01, 2024 | 1.489 |
| September 30, 2024 | 1.558 |
| September 27, 2024 | 3.929 |
| September 26, 2024 | 4.139 |
| September 25, 2024 | 4.223 |
| September 24, 2024 | 4.013 |
| September 23, 2024 | 3.942 |
| September 20, 2024 | 4.010 |
| September 19, 2024 | 4.081 |
| September 18, 2024 | 3.923 |
| September 17, 2024 | 3.936 |
| September 16, 2024 | 3.911 |
| September 13, 2024 | 4.022 |
| September 12, 2024 | 3.869 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7741
Minimum
Jun 14 2022
9.983
Maximum
Feb 11 2021
2.866
Average
1.591
Median
Sep 28 2021
Price to Book Value Benchmarks
| Pfizer Inc | 1.543 |
| Regeneron Pharmaceuticals Inc | 2.790 |
| Ligand Pharmaceuticals Inc | 2.626 |
| ADMA Biologics Inc | 21.71 |
| AnaptysBio Inc | 7.641 |
Price to Book Value Related Metrics
| PE Ratio | 4.890 |
| PS Ratio | 96.13 |
| Price | 55.55 |
| Earnings Yield | 20.45% |
| Market Cap | 3.168B |